Asher Bio Competitors and Similar CompaniesClear all
Asher Bio's competitors and similar companies include Zymeworks, Coherus Oncology, Foghorn Therapeutics and Gossamer Bio.
 Asher Bio Asher Bio (also known as Asher Biotherapeutics) is a biotechnology company developing cis-targeted immunotherapies for cancer and other diseases. |  Zymeworks Zymeworks is a computational biotechnology company focused on optimizing therapeutic antibodies and other protein-based therapeutics. |  Coherus Oncology Coherus BioSciences is a biopharmaceutical company that focuses on the research, development, and commercialization of cancer treatments. |  Foghorn Therapeutics Foghorn Therapeutics is a developer of gene therapies for hematologic cancers and solid tumors. |  Gossamer Bio Gossamer Bio is a company focused on the discovery and development of novel and differentiated therapeutic products, to address high unmet needs amongst various targeted patient populations. | |
Founding Date | Founding Date 2019 | Founding Date 2003 | Founding Date 2010 | Founding Date 2016 | Founding Date 2015 |
Type | Type Private | Type Public | Type Public | Type Public | Type Public |
Tags | |||||
Locations | Locations South San Francisco, US HQ | Locations Vancouver, CA HQ Seattle, US | Locations Redwood City, US HQ Camarillo, US | Locations Cambridge, US HQ Cambridge, US | Locations San Diego, US HQ Dublin 2, IE |
Employees | Employees 287% decrease | Employees 45519% increase | Employees 14736% decrease | Employees 1123% decrease | Employees 11820% increase |
Valuation ($) | Valuation ($) N/A | Valuation ($) 973.3 m | Valuation ($) 85.6 m | Valuation ($) 452 m | Valuation ($) 208 m |
Financial | |||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) $106m (FY, 2025) | Revenue (est.) $42.2m (FY, 2025) | Revenue (est.) $30.9m (FY, 2025) | Revenue (est.) $48.5m (FY, 2025) |
Net income | Net income N/A | Net income ($81.1m) (FY, 2025) | Net income $168m (FY, 2025) | Net income ($74.4m) (FY, 2025) | Net income ($170.4m) (FY, 2025) |
Funding | |||||
Total funding raised | Total funding raised $ 55.2m | Total funding raised $ 125.9m | Total funding raised $ 174.5m | Total funding raised $ 50m | Total funding raised $ 480m |
For sources of this data, please see the company profile
View Company Profiles
Zymeworks
HQ
Vancouver, CA
Employees
455↑ 19% increase
Zymeworks is a computational biotechnology company focused on optimizing therapeutic antibodies and other protein-based therapeutics.
View companyCoherus Oncology
HQ
Redwood City, US
Employees
147↓ 36% decrease
Coherus BioSciences is a biopharmaceutical company that focuses on the research, development, and commercialization of cancer treatments.
View companyFoghorn Therapeutics
HQ
Cambridge, US
Employees
112↓ 3% decrease
Foghorn Therapeutics is a developer of gene therapies for hematologic cancers and solid tumors.
View companyGossamer Bio
HQ
San Diego, US
Employees
118↑ 20% increase
Gossamer Bio is a company focused on the discovery and development of novel and differentiated therapeutic products, to address high unmet needs amongst various targeted patient populations.
View company